Bill Commons

NJ S 1271

in committee

Provides cancer and cardiovascular screenings to law enforcement officers; establishes fund; appropriates $20 million.

New Jersey · 222 · upper

Quick answers

Did NJ S 1271 pass?

Not yet. NJ S 1271 is in committee as of 2026-01-13 and has not come to a final vote. Latest recorded action (2026-01-13): Introduced in the Senate, Referred to Senate State Government, Wagering, Tourism & Historic Preservation Committee

What is NJ S 1271 about?

NJ S 1271 is a bill in the 222 titled “Provides cancer and cardiovascular screenings to law enforcement officers; establishes fund; appropriates $20 million.”.

Who sponsors NJ S 1271?

Greenstein, Linda R., McKeon, John F. are the primary sponsors of NJ S 1271, joined by 3 cosponsors.

Introduced
2026-01-13
Latest action
2026-01-13 — Introduced in the Senate, Referred to Senate State Government, Wagering, Tourism & Historic Preservation Committee
Bill type
bill
Last updated

Sponsors

  • Greenstein, Linda R.primary
  • McKeon, John F.primary
  • Bucco, Anthony M.cosponsor
  • Diegnan, Patrick J., Jr.cosponsor
  • Burgess, Renee C.cosponsor

Committees

Not provided by source.

Action timeline

  1. 2026-01-13

    Introduced in the Senate, Referred to Senate State Government, Wagering, Tourism & Historic Preservation Committee

    introduction,referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=S 1271. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.